Spironolactone Tablet
Product Images NDC 71610-102

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 71610-102). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 25 mg (71610 0102 60)

Label for Spironolactone 25 mg oral tablets, containing 90 tablets per bottle. The label shows the NDC number 71610-0102-60, manufactured by Arneal Pharmaceuticals Pvt. Ltd. in Ahmedabad, India, and repackaged by Aphena Pharma Solutions - Tennessee, LLC in Cookeville, TN. Storage instructions and RX only designation are also visible.*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

20 (Spironolactone Tablets Usp 1)

Chemical structure of Spironolactone depicted as a detailed molecular diagram showing its steroid backbone and attached functional groups.*

FDA Label Image

10 (Spironolactone Tablets Usp 2)

A Kaplan-Meier survival probability graph comparing Spironolactone and Placebo groups over 48 months. The y-axis shows probability from 0 to 1, and the x-axis shows time in months. Two curves are displayed: a dashed line for Spironolactone (n=822) and a solid line for Placebo (n=841), indicating higher survival probability in the Spironolactone group. A log-rank p-value of less than 0.001 is noted.*

FDA Label Image

10 (Spironolactone Tablets Usp 3)

A forest plot chart showing hazard ratios (HR) and 95% confidence intervals (CI) for different subgroups in a study, including Age, Sex, Race, LVEF %, Heart Failure type, NYHA class, Diabetes status, Serum Creatinine levels, Creatinine Clearance, Potassium levels, Digoxin use, ACE inhibitor use, and Beta Blocker use. Each subgroup's data point with confidence intervals is plotted against a scale ranging from 0.2 to 1.4, with annotations indicating "Spironolactone better" on the left and "Placebo better" on the right.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.